Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 29, 2015, 42 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $800.00 to $5,120,921.47.

Highlighted Stocks Traded by Insiders:

McGraw Hill Financial (MHFI) - FREE Research Report

Neal Lawrence, who is President, Platts at McGraw Hill Financial, sold 1,043 shares at $103.65 on June 29, 2015. Following this transaction, the President, Platts owned 19,207 shares meaning that the stake was reduced by 5.15% with the 1,043-share transaction.

The shares most recently traded at $101.23, down $2.42, or 2.39% since the insider transaction. Historical insider transactions for McGraw Hill Financial go as follows:

  • 4-Week # shares bought: 400
  • 4-Week # shares sold: 4,372
  • 12-Week # shares bought: 400
  • 12-Week # shares sold: 4,372
  • 24-Week # shares bought: 400
  • 24-Week # shares sold: 88,874

The average volume for McGraw Hill Financial has been 1.1 million shares per day over the past 30 days. McGraw Hill Financial has a market cap of $28.4 billion and is part of the services sector and diversified services industry. Shares are up 13.07% year-to-date as of the close of trading on Monday.

McGraw Hill Financial, Inc. provides benchmarks and ratings, analytics, data, and research services for the capital, commodities, and commercial markets worldwide. The stock currently has a dividend yield of 1.27%. Currently, there are 7 analysts who rate McGraw Hill Financial a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MHFI - FREE

TheStreet Quant Ratings

rates McGraw Hill Financial as a

hold

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk, disappointing return on equity and weak operating cash flow. Get the full

McGraw Hill Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Intermolecular (IMI) - FREE Research Report

Neely Rick, who is SVP & Chief Financial Officer at Intermolecular, sold 34,537 shares at $1.94 on June 29, 2015. Following this transaction, the SVP & Chief Financial Officer owned 92,709 shares meaning that the stake was reduced by 27.14% with the 34,537-share transaction.

The shares most recently traded at $2.16, up $0.22, or 10.07% since the insider transaction. Historical insider transactions for Intermolecular go as follows:

  • 4-Week # shares bought: 50,000
  • 4-Week # shares sold: 6,727
  • 12-Week # shares bought: 50,000
  • 12-Week # shares sold: 6,727
  • 24-Week # shares bought: 50,000
  • 24-Week # shares sold: 6,727

The average volume for Intermolecular has been 87,600 shares per day over the past 30 days. Intermolecular has a market cap of $104.0 million and is part of the technology sector and electronics industry. Shares are up 11.4% year-to-date as of the close of trading on Monday.

Intermolecular, Inc. develops and applies high productivity combinatorial (HPC) research and development technologies for the semiconductor and clean energy industries worldwide. Currently, there is 1 analyst who rates Intermolecular a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IMI - FREE

TheStreet Quant Ratings

rates Intermolecular as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Intermolecular Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

IHS (IHS) - FREE Research Report

Matzke-Hamlin Heather, who is Sr VP, Chief Acctg Officer at IHS, sold 673 shares at $133.99 on June 29, 2015. Following this transaction, the Sr VP, Chief Acctg Officer owned 11,748 shares meaning that the stake was reduced by 5.42% with the 673-share transaction.

Sweeney Brian J., who is Sr VP, Global Sales at IHS, sold 750 shares at $133.99 on June 29, 2015. Following this transaction, the Sr VP, Global Sales owned 4,945 shares meaning that the stake was reduced by 13.17% with the 750-share transaction.

The shares most recently traded at $128.98, down $5.01, or 3.88% since the insider transaction. Historical insider transactions for IHS go as follows:

  • 4-Week # shares sold: 1,500
  • 12-Week # shares sold: 1,500
  • 24-Week # shares sold: 22,836

The average volume for IHS has been 366,700 shares per day over the past 30 days. IHS has a market cap of $9.0 billion and is part of the technology sector and computer software & services industry. Shares are up 13.44% year-to-date as of the close of trading on Monday.

IHS Inc. provides critical information, insights, and analytics worldwide. The company has a P/E ratio of 46.4. Currently, there are 6 analysts who rate IHS a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IHS - FREE

TheStreet Quant Ratings

rates IHS as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

IHS Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.